FORWARD FEATURES CALENDAR

Intel

Cinven to invest in Flint Global

Cinven is making a majority investment in Flint Global, a specialist professional services firm which advises corporates and investors on regulatory, policy, competition and economics matters. Financial details of the transaction were not disclosed.

Medline targets $55bn valuation in mega PE-backed IPO

Medline, the medical supply manufacturer backed by Blackstone, Carlyle, and Hellman & Friedman, is targeting a $55bn valuation in a US IPO which would make it one of the largest PE-backed listings ever, according to a report by Reuters.

Bain Capital and SMBC Launch €1.5bn joint lending platform

Bain Capital, a global private investment firm, has launched a joint venture with bookrunner SMBC to establish a new European loan platform providing up to €1.5bn in senior secured credit to corporate borrowers across Europe and the UK. The platform is structured as a co-governed credit vehicle, combining SMBC’s pan-European

Stifel co-heads exit Eaton Partners subsidiary

Stifel Financial executives Dirk Jonske and Adrian Siew have left the firm’s Eaton Partners subsidiary, where they co-led the GP Solutions advisory business, focused on private market fundraising in the secondary market, according to a report by Bloomberg.

EQT moves to reassure investors over co-investment fee plans

Swedish investment firm EQT has sought to reassure institutional investors that it does not plan to charge fees on co-investments following comments by Chief Executive Per Franzen that raised concerns among clients, according to a report by Bloomberg.

HongShan submits €2.5bn offer for Permira-owned Golden Goose

China-based HongShan Capital Group has submitted a €2.5bn ($2.91bn) offer to buy Italian luxury sneaker maker Golden Goose from private equity firm Permira, according to a report by la Repubblica. The parties are reportedly aiming to sign a deal by Christmas.

L’Oréal doubles Galderma stake to 20% in deal with EQT-led group

L’Oréal has agreed to double its stake in Galderma Group to 20% as it deepens its exposure to the fast-growing injectable aesthetics market, according to a report by Bloomberg. The shares are being acquired from an investor consortium led by private equity firm EQT, although financial terms were not disclosed.

Events

12 November, 2026 – 5:00 pm

Directory Listings